Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric ( primate/ human) |
Target | CD80 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
(what is this?) (verify) |
Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. [1] As of September 2009 [update], it is undergoing Phase III clinical trials. [2] The drug is a chimeric antibody from Macaca irus and Homo sapiens. [3]